Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CD28 | P10747 | T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28) | CD markersPredicted membrane proteins | 1 | Brain cancerDiabetes mellitusImmune system disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.53 | ||
| CD38 | P28907 | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPR hydrolase 1) (T10) (CD antigen CD38) | Cancer-related genesCD markersEnzymes | 1 | Diabetes mellitusAcute myeloid leukaemiaB-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.53 | ||
| CD3G | P09693 | T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g) | CD markersDisease related genesFDA approved drug targets | 1 | Breast cancerColorectal cancerMalignant digestive organ neoplasm | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.53 | ||
| CF418 | Q96NL8 | Cilia- and flagella-associated protein 418 | Disease related genesHuman disease related genesPredicted intracellular proteins | Bardet-Biedl syndromeCone-rod dystrophyObesity | Other mediation | 2 | 0.53 | |||
| CLCN6 | P51797 | H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6) | Disease related genesPlasma proteinsPredicted membrane proteins | 10 | Neuronal ceroid lipofuscinosis | Clinical-translation mediationFusion and delivery mediation | 2 | 0.53 | ||
| CNR1 | P21554 | Cannabinoid receptor 1 (CB-R) (CB1) (CANN6) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Obesity | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.53 | ||
| CTND1 | O60716 | Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)) | Cancer-related genesDisease related genesHuman disease related genes | Ectodermal dysplasia | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.53 | |||
| CY24B | P04839 | NADPH oxidase 2 (EC 1.6.3.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Cytochrome b-245 heavy chain) (Heme-binding membrane glycoprotein gp91phox) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome) | Disease related genesHuman disease related genesPotential drug targets | 6 | Chronic granulomatous disease | Fusion and delivery mediationImmune mediationMetabolism mediation | 2 | 0.53 | ||
| CYBC1 | Q9BQA9 | Cytochrome b-245 chaperone 1 (Essential for reactive oxygen species protein) (Eros) | Disease related genesHuman disease related genesPredicted intracellular proteins | 1 | Chronic granulomatous disease | Other mediation | 2 | 0.53 | ||
| DIAP1 | O60610 | Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1) | Cancer-related genesDisease related genesHuman disease related genes | DeafnessEpilepsyNon-syndromic deafness | Fusion and delivery mediationImmune mediationMetabolism mediation | 2 | 0.53 |